Total Visits

Views
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database78

Select a period of time:

Views

Views
September 20250
October 20258
November 20251
December 20252
January 202612
February 20260
March 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Finland5
Brazil3
United Kingdom2
Australia1
Colombia1
Ethiopia1
Tunisia1
South Africa1
 

Top cities views

Views
Helsinki5
Addis Ababa1
Arapiraca1
Johannesburg1
Kansas City1
Los Angeles1
Montería1
Picuí1
Tunis1
Wagner1